Site Under Construction

A translation and validation study of the Filipino version of the Psoriasis Epidemiology Screening Tool (PEST) among Filipino patients with psoriasis seen at the Rizal Medical Center

Camille Clarisse S. Mundin, MD, Rogelio B. Balagat MD, FPCP, FPDS, FPRA, Jamie P. Nuñez MD, FPDS

Abstract

Introduction

Psoriasis is a chronic autoimmune disease that affects the skin, nails, and musculoskeletal system. Musculoskeletal involvement, called psoriatic arthritis occurs in 10-25% of patients with psoriasis and can lead to disability if left untreated. Early detection and intervention of psoriatic arthritis has been shown to decrease morbidity.

The Psoriasis Epidemiology Screening Tool (PEST) may detect the presence of psoriatic arthritis and has been validated in different countries. Currently, there is no Filipino version.

 

Objectives

To translate, adapt, and validate PEST in Filipino language.

 

Methods

In the first part of the study, PEST was translated and culturally adapted into Filipino. It was pretested in 30 participants. Three experts then assessed its content and face validity. After the content and face validity were met, 115 participants answered the Filipino version of the PEST questionnaire.

Results

The Filipino version of the PEST questionnaire was comprehensible, clear and appropriate. All questions were relevant. Some words were edited per expert recommendation. One hundred fifteen adult patients were asked to answer the questionnaire. It showed good reliability at 94%.

Conclusion

The Filipino Version of the PEST was found to be reliable and valid. Larger samples to determine the tool’s applicability is recommended.

 

 

References

  1. Wolff K, Goldsmith L, Katz S, Gilchrest B, Paller AS, Leffell D. Fitzpatrick’s Dermatology in General Medicine, 8th Edition. New York: McGraw-Hill, 2011.
  2. Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence. Journal of Investigative Dermatology. 2013Feb;133(2):377–85.
  3. Gladman D, Antoni C, Mease P, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. 2005Mar;64:ii14–ii17.
  4. Elmets C, Leonardi C, Davis D, Gelfand J, Lichten J, Mehta N, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. Journal of the American Academy of Dermatology. 2019;80(4):1073-1113.
  5. Firestein G, Gabriel S, McInnes I, O’Dell J. Kelley and Firestein’s textbook of rheumatology.
  6. Villani AP, Rouzaud M, Sevrain M, Barnetche T, Paul C, Richard MA, et al. Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis. J Am Acad Dermatol. 2015 Aug;73(2):242-8. doi: 10.1016/j.jaad.2015.05.001. Epub 2015 Jun 6. PMID: 26054432.
  7. Mease PJ, Gladman DD, Papp KA, Khraishi MM, Thaçi D, Behrens F, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol. 2013 Nov;69(5):729-735. doi: 10.1016/j.jaad.2013.07.023. Epub 2013 Aug 24. PMID: 23981683.
  8. Reich K, Krüger K, Mössner R, Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol. 2009;160(5):1040-1047. DOI:10.1111/j.1365-2133.2008.09023.x
  9. Lim W, How C, Tan K. Management of psoriasis in primary care. Singapore Medical Journal. 2021;62(3):109-112.
  10. Evaluation of an existing screening tool for psoriatic … [Internet]. [cited 2020Jan21]. Available from: https://pdfs.semanticscholar.org/54f1/8c445e82ba48bbcafdb363a87f5f8b59c0fd.pdf
  11. Mease PJ, Palmer JB, Hur P, Strober BE, Lebwohl M, Karki C, et al. Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross-sectional analysis from the US-based Corrona Psoriasis Registry. J Eur Acad Dermatol Venereol. 2019 May;33(5):886-892. doi: 10.1111/jdv.15443. Epub 2019 Mar 5. PMID: 30663130; PMCID: PMC6593969.
  12. Tsang S, Royse C, Terkawi A. Guidelines for developing, translating, and validating a questionnaire in perioperative and pain medicine. Saudi Journal of Anaesthesia. 2017;11(5):80.
  13. Two Criteria for Good Measurements in Research: Validity and Reliability – Munich Personal RePEc Archive [Internet]. Mpra.ub.uni-muenchen.de. 2021 [cited 15 October 2021]. Available from: https://mpra.ub.uni-muenchen.de/83458/
  14. Perneger, Thomas V., Delphine S. Courvoisier, Patricia M. Hudelson, and Angèle Gayet-Ageron. 2015. “Sample Size for Pre-Tests of Questionnaires.” Quality of Life Research 24 (1): 147–51. DOI:10.1007/s11136-014-0752-2.
  15. Daniel WW (1999). Biostatistics: A Foundation for Analysis in the Health Sciences. 7th edition. New York: John Wiley & Sons.
  16. Helliwell PS. Psoriasis Epidemiology Screening Tool (PEST): a report from the GRAPPA 2009 annual meeting. J Rheumatol. 2011;38(3):551-552. DOI:10.3899/jrheum.101119
  17. Lu C, Leng X, Zeng X, Long Y, Shi Y. Validating the Chinese version of the psoriasis epidemiology screening tool and early arthritis for psoriatic patients questionnaires. Chin Med J (Engl). 2021;134(11):1367-1369. DOI:10.1097/cm9.0000000000001460
  18. Mazzotti NG, Palominos PE, Bredemeier M, Kohem CL, Cestari TF. Cross-cultural validation and psychometric properties of the Brazilian Portuguese version of the Psoriasis Epidemiology Screening Tool (PEST-bp). Arch Dermatol Res. 2020;312(3):197-206. DOI:10.1007/s00403-019-02013-9
  19. Lajevardi V, Ghodsi SZ, Shafiei M, Teimourpour A, Etesami I. Evaluating the Persian versions of two psoriatic arthritis screening questionnaires early arthritis for psoriatic patients questionnaire (EARP) and psoriasis epidemiology screening tool (PEST) in Iranian psoriatic patients. Turk J Med Sci. 2021;51(1):159-166. Published 2021 Feb 26. DOI:10.3906/sag-2006-372
  20. Chularojanamontri L, Junsuwan N, Silpa-archa N, Wongpraparut C, Chiowchanwisawakit P. Utility of the Siriraj Psoriatic Arthritis Screening Tool, the Thai Psoriasis Epidemiology Screening Tool, and the Early Arthritis for Psoriatic Patients Questionnaire to Screen for Psoriatic Arthritis in an Outpatient Dermatology Clinic Setting, and Identification of Factors Significantly Associated with Psoriatic Arthritis. Siriraj Med J. 2019;71(5):405-413. DOI:10.33192/smj.2019.61
Download Here

Menu

Journal Sections

Legal

A Product of the PDS

Philippine Dermatological Society

Follow us on social media

Facebook Twitter Instagram

© 2022 Philippine Dermatological Society. All rights reserved.

Menu

Journal Sections

Legal

A Product of the PDS

Philippine Dermatological Society

Follow us on social media

Facebook Twitter Instagram

© 2022 Philippine Dermatological Society.

All rights reserved.

REquesting Permission

A translation and validation study of the Filipino version of the Psoriasis Epidemiology Screening Tool (PEST) among Filipino patients with psoriasis seen at the Rizal Medical Center